Cite

HARVARD Citation

    Olszanski, A. et al. (2016). Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors. Oncologist. pp. 402-403f. [Online]. 
  
Back to record